Consumer: Covestus’ acquisitions of UltraDEX and Dentyl 

Armstrong provided commercial due diligence to Covestus Holdings Ltd (Covestus), a consumer health and pharmaceutical group and Maven portfolio company, for its acquisitions of UltraDEX and Dentyl.

The addition of UltraDEX, a clinically supported halitosis treatment range, and Dentyl, a leading mouthwash brand, expands Covestus’ footprint in oral care and strengthens its position in the UK and international markets.

Armstrong provided in-depth customer referencing together with market and competitor analysis.

Quentin Higham, CEO at Covestus said, “Armstrong’s commercial oral care market analysis and business intelligence played an integral role in our due diligence. The Armstrong team demonstrated perseverance, tenacity and good trading insight.”

Peter Cookson, Managing Partner at Armstrong said, “We are excited to have supported Covestus and Maven as they embark on creating a unique platform of specialist brands addressing under-served chronic conditions and preventative health needs.”  

Armstrong has extensive experience in the consumer and travel sector, and in helping Private Equity and Portfolio companies identify opportunities and generate value through implementing buy and build strategies across a broad range of sectors. 

To discuss similar opportunities, please contact: 

Peter Cookson

pcookson@armstrong-ts.com
+44 7871 425 467